MedPath

GLUCOVANCE

GLUCOVANCE (Glyburide and Metformin HCl) Tablets

Approved
Approval ID

ff281ebd-29c2-4852-a8ab-c4f21abe8b7c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 23, 2012

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

GLYBURIDE AND METFORMIN HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-4609
Application NumberNDA021178
Product Classification
M
Marketing Category
C73594
G
Generic Name
GLYBURIDE AND METFORMIN HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateApril 23, 2012
FDA Product Classification

INGREDIENTS (6)

glyburideActive
Quantity: 2.5 mg in 1 1
Code: SX6K58TVWC
Classification: ACTIB
metformin hydrochlorideActive
Quantity: 500 mg in 1 1
Code: 786Z46389E
Classification: ACTIB
cellulose, microcrystallineInactive
Code: OP1R32D61U
Classification: IACT
povidoneInactive
Code: FZ989GH94E
Classification: IACT
croscarmellose sodiumInactive
Code: M28OL1HH48
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLUCOVANCE - FDA Drug Approval Details